Zhao Zhao WH WH A phase 1, open-label study of LCAR-B38M, a chimeric antigen receptor T cell therapy directed against B cell maturation antigen, in patients with relapsed or refractory multiple myeloma A phase 1, open-label study of LCAR-B38M, a chimeric antigen receptor T cell therapy directed against B cell maturation antigen, in patients with relapsed or refractory multiple myeloma J Hematol Oncol J Hematol Oncol 2018 2018 11 11 1 1 141 141 10.1186/s13045-018-0681-6 10.1186/s13045-018-0681-6 30572922 30572922. This evidence concerns the gene TNFRSF17 and plasma cell myeloma.